Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate-to-severe Inflammatory Bowel Disease”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04677179
What this trial is testing

LY3471851 in Adult Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Nektar Therapeutics 81
Testing effectiveness (Phase 2)Study completedNCT03093259
What this trial is testing

ABX464 in Subjects With Moderate to Severe Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Abivax S.A. 32
Testing effectiveness (Phase 2)Study completedNCT02536404
What this trial is testing

Extension Study of APD334-003 in Patients With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Arena Pharmaceuticals 118
Testing effectiveness (Phase 2)Looking for participantsNCT05287126
What this trial is testing

Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Pfizer 36
Testing effectiveness (Phase 2)Active Not RecruitingNCT06127043
What this trial is testing

Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Ulcerative Colitis (ROSETTA)

Who this might be right for
Ulcerative Colitis
AnaptysBio, Inc. 132
Early research (Phase 1)Looking for participantsNCT06754891
What this trial is testing

Clinical Trial of TQH3906 Capsules for the Treatment of Adult Patients With Moderately to Severely Active Ulcerative Colitis or Crohn's Disease

Who this might be right for
Inflammatory Bowel Diseases
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 135
Large-scale testing (Phase 3)Looking for participantsNCT06100289
What this trial is testing

Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda 70
Testing effectiveness (Phase 2)Study completedNCT02531113
What this trial is testing

Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Celgene 69
Testing effectiveness (Phase 2)WithdrawnNCT04151225
What this trial is testing

Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease

Who this might be right for
Crohns DiseaseCrohn's Disease
GlaxoSmithKline
Testing effectiveness (Phase 2)Study completedNCT00572585
What this trial is testing

Efficacy, Safety and Tolerability of AEB071 in Patients With Active, Moderate to Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT03675477
What this trial is testing

A Phase II Study in Patients With Moderate to Severe Active Ulcerative Colitis.

Who this might be right for
Ulcerative Colitis
Reistone Biopharma Company Limited 164
Large-scale testing (Phase 3)Study completedNCT03345836
What this trial is testing

The Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Biologic Therapy

Who this might be right for
Crohn's Disease
AbbVie 624
Large-scale testing (Phase 3)Looking for participantsNCT06937086
What this trial is testing

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

Who this might be right for
Ulcerative ColitisObesity or Overweight
Eli Lilly and Company 350
Large-scale testing (Phase 3)Study completedNCT04630028
What this trial is testing

Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

Who this might be right for
Colitis, Ulcerative
Janssen Research & Development, LLC 112
Large-scale testing (Phase 3)Ended earlyNCT00295165
What this trial is testing

Efficacy (Induction of Response/Remission) and Safety Study in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn Disease
Genzyme, a Sanofi Company 33
Testing effectiveness (Phase 2)Active Not RecruitingNCT05910528
What this trial is testing

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

Who this might be right for
Crohns Disease
Hoffmann-La Roche 21
Testing effectiveness (Phase 2)UnknownNCT05907330
What this trial is testing

Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Curacle Co., Ltd. 45
Large-scale testing (Phase 3)Study completedNCT03653026
What this trial is testing

The Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

Who this might be right for
Ulcerative Colitis (UC)
AbbVie 522
Testing effectiveness (Phase 2)WithdrawnNCT02913508
What this trial is testing

Vedolizumab Subcutaneous (SC) Versus Intravenous (IV) in Ulcerative Colitis or Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Takeda
Large-scale testing (Phase 3)Study completedNCT04673357
What this trial is testing

Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 101
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation